clinical trial · NCT07523750
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
Biosense Webster, Inc.·N/A·recruiting·n = 466
Atrial FibrillationVARIPULSE CatheterFARAWAVE Catheter
brief summary
The purpose of this study is to assess how safe VARIPULSE pulsed field ablation (PFA) catheter is and how well it works compared to food and drug administration (FDA) approved FARAWAVE PFA catheter in participants with symptomatic persistent atrial fibrillation (PsAF; continuous irregular, rapid heartbeat that lasts over 7 days and doesn't stop on its own).
started
Apr 6, 2026
primary completion
May 31, 2028
completion
May 31, 2028
last updated
Apr 22, 2026
official title
Comparison of Safety and Effectiveness of a VARIPULSE™ PFA Catheter to FARAWAVE™ PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation: A Randomized Controlled Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol